MD Medical Group IPJSC

MD Medical Group IPJSC

MMOEX:MDMG
1,283.30
RUB
+2.50
(+0.20%)
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
Revenue per Share
0.03
46.52
62.27
75.51
95.97
126.94
162.62
183.66
199.11
215.12
254.69
335.7
335.73
Basic EPS, GAAP
0.01
13.76
21.46
8.47
15.94
21.41
27.58
33.23
35.61
35.11
55.86
79.91
60.7
Free Cash Flow per Basic Share
0.01
-11.96
-12.72
-10.25
-13.7
27.11
28.22
9.66
4.79
12.69
34.75
62.68
87.38
Dividend per Share
- -
0.02
2.36
4.18
2.4
4.01
10.49
9.09
6.59
10.5
29.43
36.3
8.48
Book Value per Share
- -
34.34
110.25
117.27
130.24
147.58
164.36
188.24
208.95
233.46
261.02
303.93
356.08
Tangible Book Value per Share
- -
33.93
109.84
111.26
103.79
119.03
131.86
157.15
178.88
204.27
231.66
275.42
329.99
Basic Weighted Avg Shares
72,125
63
65
75
75
75
75
75
75
75
75
75
75
Sales/Revenue/Turnover
2,044
2,908
4,061
5,673
7,201
9,507
12,179
13,755
14,937
16,160
19,133
25,220
25,222
Operating Margin (%)
46.8
41.03
38.42
20.42
21.33
18.67
22.36
23.45
20.13
19.82
22.58
26.36
24.72
Depreciation Expense
132
99
134
428
547
881
946
1,036
1,190
1,509
1,524
1,699
1,668
Net Income, GAAP
698
860
1,399
636
1,196
1,604
2,066
2,489
2,671
2,638
4,196
6,003
4,560
Effective Tax Rate (%)
20.25
22.69
- -
8.6
5.39
1.91
- -
2.77
0.91
- -
0.11
0.25
0.16
Profit Margin (%)
34.15
29.58
34.46
11.21
16.6
16.87
16.96
18.09
17.88
16.32
21.93
23.8
18.08
Working Capital
- -
-589
3,842
1,569
-1,115
-529
-756
33
197
779
213
-641
2,074
LT Debt
- -
1,060
2,696
2,380
3,251
2,300
2,200
3,585
4,587
5,864
5,230
3,727
489
Total Equity
- -
2,807
8,623
9,209
10,137
11,509
12,770
14,568
15,999
17,880
19,953
23,097
26,963
Return on Invested Capital (%)
- -
46.02
- -
8.9
10.99
11.92
- -
17.85
14.66
- -
16.75
24.06
22.31
Return on Capital (%)
- -
40.01
- -
6.42
10.19
12.3
- -
14.53
14.18
- -
17.55
22.95
17.02
Return on Common Equity (%)
- -
66.67
25.77
7.44
12.88
15.39
17.63
18.79
17.91
15.87
22.59
28.29
18.39

Capital Structure

RUB

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

RUB

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

RUB

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
12.11%
13.14%
16.74%
Free Cash Flow
7.58%
81.75%
39.4%
Net Income, GAAP
20.1%
16.84%
-24.04%
Sales/Revenue/Turnover
20.67%
13.4%
0.01%
Total Cash Common Dividend
43.57%
31.83%
-76.65%

Quarterly Revenue

RUB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
25,220
2022
- -
- -
- -
- -
25,222
2023
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

RUB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
79.91
2022
- -
- -
- -
- -
60.7
2023
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

RUB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
36.3
2022
- -
- -
- -
- -
8.48
2023
- -
- -
- -
- -
- -

Company Description

CEO
Mark Kurtser
Full Time Employees
6,465
Sector
Health services
Industry
Hospital/Nursing management
Address
Anastasio Building Nicosia Russian Federation 2024
IPO Date
Oct 12, 2012
Business
MD Medical Group Investments Plc (MDMG.ME) operates as a private healthcare provider in Russia, offering a comprehensive range of medical services through its network of multidisciplinary clinics under the Mother and Child brand; these services encompass reproductive medicine and IVF programs, pediatrics, obstetrics and gynecology, surgical interventions, diagnostic imaging, laboratory testing, and specialized treatments for women and children. The company delivers high-quality outpatient and inpatient care, including maternity services, neonatal intensive care, and genetic counseling, targeting families, expectant mothers, and pediatric patients across its primary markets in Russia. Founded in 2006 and headquartered in Moscow, the group maintains operations predominantly in major Russian cities such as Moscow, St. Petersburg, and regional centers, with no significant international presence noted. In recent developments within the last two years, MD Medical Group has focused on network expansion through organic clinic openings and operational enhancements amid challenging market conditions; no major acquisitions, funding rounds, or strategic partnerships have been publicly announced recently, reflecting a steady emphasis on core healthcare delivery rather than transformative changes. The company functions as a standalone entity listed on the Moscow Exchange, serving as a key player in Russia's competitive private medical sector.